Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: This case was reported by a physician and described the occurrence of invagination of intestine in a 3-month-old female subject who was vaccinated with Rotarix (GlaxoSmithKline). The subject had no family history of intussusception or bowel abnormalities. The subject had no history of the following: congenital intestinal malformation, intestinal polyps, Merckel''s diverticulum, intestinal vascular malformations, cystic fibrosis, Hirschsprung disease, other gastrointestinal malformation and dysfunction. Previous vaccination included tuberculosis vaccine (manufacturer unspecified; oral) given on 18 November 2007. Concurrent vaccination included DTaP, HIB (manufacturer unspecified; intradermal; unknown) given on 23 January 2008 and hepatitis B vaccine recombinant (manufacturer unspecified; intramuscular; unknown) given on 23 January 2006. On 23 January 2008, the subject received the 1st dose of Rotarix (oral). On unspecified date, at unspecified time after vaccination with the 1st dose of Rotarix, the subject experienced intestinal invagination. On 29 February 2008, a reduction of intestinal invagination was performed in hospital and was without complications. The subject was discharged with good conditions; however she needed to go to the same hospital on 05 March 2008 with similar symptoms. The subject was hospitalised and the physician considered the event was clinically significant (or requiring intervention). Plain abdominal radiograph, abdominal ultrasound and abdominal CT were not performed. On 05 March 2008, the subject required again an intervention. Finding: interstinal invagination, corroborating on second surgery type colo-colic-cecolic, reduction was performed without complications. The subject did not have a bowel resection. The subject was transferred to another hospital on 10 March 2008 to continue with surveillance. The subject was stable, abdomen was tender and she was without evidence of post-surgery complications. She presented good oral tolerance, normal evacuations and she was without notice of
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166